Patel, K. K., Spooner, C., Giordana, M., Shuler, T., Myers, D., Mateos, M. (2026). Anitocabtagene autoleucel (anito-cel) clinical trial manufacturing experience in patients with relapsed/refractory (RR) or newly diagnosed (ND) multiple myeloma (MM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2550